CDTX
Price
$20.70
Change
-$2.11 (-9.25%)
Updated
Dec 18, 04:59 PM (EDT)
NRXP
Price
$1.54
Change
-$0.10 (-6.10%)
Updated
Dec 18, 04:59 PM (EDT)
Ad is loading...

CDTX vs NRXP

Header iconCDTX vs NRXP Comparison
Open Charts CDTX vs NRXPBanner chart's image
Cidara Therapeutics
Price$20.70
Change-$2.11 (-9.25%)
Volume$4.69K
CapitalizationN/A
NRX Pharmaceuticals
Price$1.54
Change-$0.10 (-6.10%)
Volume$863
CapitalizationN/A
CDTX vs NRXP Comparison Chart
Loading...
CDTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NRXP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CDTX vs. NRXP commentary
Dec 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CDTX is a Hold and NRXP is a StrongBuy.

COMPARISON
Comparison
Dec 19, 2024
Stock price -- (CDTX: $22.81 vs. NRXP: $1.64)
Brand notoriety: CDTX and NRXP are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CDTX: 119% vs. NRXP: 652%
Market capitalization -- CDTX: $249.52M vs. NRXP: $19.83M
CDTX [@Biotechnology] is valued at $249.52M. NRXP’s [@Biotechnology] market capitalization is $19.83M. The market cap for tickers in the [@Biotechnology] industry ranges from $486.73B to $0. The average market capitalization across the [@Biotechnology] industry is $2.68B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CDTX’s FA Score shows that 1 FA rating(s) are green whileNRXP’s FA Score has 0 green FA rating(s).

  • CDTX’s FA Score: 1 green, 4 red.
  • NRXP’s FA Score: 0 green, 5 red.
According to our system of comparison, CDTX is a better buy in the long-term than NRXP.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CDTX’s TA Score shows that 3 TA indicator(s) are bullish while NRXP’s TA Score has 4 bullish TA indicator(s).

  • CDTX’s TA Score: 3 bullish, 4 bearish.
  • NRXP’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, NRXP is a better buy in the short-term than CDTX.

Price Growth

CDTX (@Biotechnology) experienced а +2.89% price change this week, while NRXP (@Biotechnology) price change was +35.54% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -6.67%. For the same industry, the average monthly price growth was -1.91%, and the average quarterly price growth was -1.42%.

Reported Earning Dates

CDTX is expected to report earnings on Aug 13, 2024.

NRXP is expected to report earnings on May 14, 2024.

Industries' Descriptions

@Biotechnology (-6.67% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CDTX($250M) has a higher market cap than NRXP($19.8M). CDTX YTD gains are higher at: 43.640 vs. NRXP (-64.348). CDTX has less debt than NRXP: CDTX (4.65M) vs NRXP (6.78M).
CDTXNRXPCDTX / NRXP
Capitalization250M19.8M1,263%
EBITDAN/AN/A-
Gain YTD43.640-64.348-68%
P/E RatioN/A0.36-
RevenueN/AN/A-
Total CashN/A16.5M-
Total Debt4.65M6.78M69%
FUNDAMENTALS RATINGS
CDTX vs NRXP: Fundamental Ratings
CDTX
NRXP
OUTLOOK RATING
1..100
8425
VALUATION
overvalued / fair valued / undervalued
1..100
32
Undervalued
61
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
100100
PRICE GROWTH RATING
1..100
3565
P/E GROWTH RATING
1..100
10094
SEASONALITY SCORE
1..100
8547

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CDTX's Valuation (32) in the Biotechnology industry is in the same range as NRXP (61) in the null industry. This means that CDTX’s stock grew similarly to NRXP’s over the last 12 months.

CDTX's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as NRXP (100) in the null industry. This means that CDTX’s stock grew similarly to NRXP’s over the last 12 months.

CDTX's SMR Rating (100) in the Biotechnology industry is in the same range as NRXP (100) in the null industry. This means that CDTX’s stock grew similarly to NRXP’s over the last 12 months.

CDTX's Price Growth Rating (35) in the Biotechnology industry is in the same range as NRXP (65) in the null industry. This means that CDTX’s stock grew similarly to NRXP’s over the last 12 months.

NRXP's P/E Growth Rating (94) in the null industry is in the same range as CDTX (100) in the Biotechnology industry. This means that NRXP’s stock grew similarly to CDTX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CDTXNRXP
RSI
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
80%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
82%
Bullish Trend 2 days ago
64%
Momentum
ODDS (%)
N/A
Bullish Trend 2 days ago
65%
MACD
ODDS (%)
N/A
Bullish Trend 2 days ago
76%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
66%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
71%
Advances
ODDS (%)
Bullish Trend 3 days ago
88%
N/A
Declines
ODDS (%)
Bearish Trend 7 days ago
90%
Bearish Trend 14 days ago
89%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
86%
Aroon
ODDS (%)
Bullish Trend 2 days ago
81%
N/A
View a ticker or compare two or three
Ad is loading...
CDTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NRXP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GME31.261.82
+6.18%
GameStop Corp
TSLA479.8616.84
+3.64%
Tesla
AAPL253.482.44
+0.97%
Apple
BTC.X106140.600000110.890625
+0.10%
Bitcoin cryptocurrency
SPY604.29-2.50
-0.41%
SPDR® S&P 500® ETF Trust

CDTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, CDTX has been closely correlated with PIRS. These tickers have moved in lockstep 96% of the time. This A.I.-generated data suggests there is a high statistical probability that if CDTX jumps, then PIRS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CDTX
1D Price
Change %
CDTX100%
-1.93%
PIRS - CDTX
96%
Closely correlated
N/A
WINT - CDTX
94%
Closely correlated
-3.77%
NBY - CDTX
93%
Closely correlated
-4.86%
NCNA - CDTX
93%
Closely correlated
+1.19%
SNPX - CDTX
93%
Closely correlated
-1.99%
More

NRXP and

Correlation & Price change

A.I.dvisor indicates that over the last year, NRXP has been closely correlated with PIRS. These tickers have moved in lockstep 86% of the time. This A.I.-generated data suggests there is a high statistical probability that if NRXP jumps, then PIRS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NRXP
1D Price
Change %
NRXP100%
+36.67%
PIRS - NRXP
86%
Closely correlated
N/A
CDTX - NRXP
85%
Closely correlated
-1.93%
NBY - NRXP
84%
Closely correlated
-4.86%
NCNA - NRXP
84%
Closely correlated
+1.19%
RNAC - NRXP
83%
Closely correlated
-2.71%
More